FR · antibody · biotech · immunology
One round we have observed, with the investors the report named. Every figure below came from a named source, and where the company reported the raise to the SEC itself, that is shown beside it.
Series A · Jun 2026 · $165M
Sofinnova Partners lead, Jeito Capital lead, Sanofi Ventures, Vives Partners, Apollo Health Ventures, Arkin Bio, Sixty Degree Capital
Reported by Ventureburn
Missing a round, or an investor who was in one? Tell us.